Pirfenidone in Treating Patients With Fibrosis Caused by Radiation Therapy for Cancer
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Pirfenidone may prevent or lessen fibrosis caused by radiation therapy.
PURPOSE: Pilot trial to study the effectiveness of pirfenidone in preventing or lessening
fibrosis in patients who have undergone radiation therapy for cancer.